Cortisol, testosterone, and pain levels among patients undergoing McKenzie therapy and suboccipital relaxation by Miecznikowski, Witold et al.
34 www.journals.viamedica.pl/medical_research_journal
ORIGINAL ARTICLE
Witold Miecznikowski1, Paweł Kiczmer2 , Karolina Cygan3, Krzysztof Starszak2 , Elżbieta Świętochowska2
1Department of Orthopaedics, Medical University of Silesia, Trauma Centre, Sosnowiec, Poland
2Department of Medical and Molecular Biology, Medical University of Silesia, Zabrze, Poland
3Safmed clinic, Sosnowiec, Poland
Cortisol, testosterone, and pain 
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relaxation
ABSTRACT
Sedentary lifestyle and the development of consumer electronics, often associated with a faulty posture, are 
widespread factors contributing to cervical spine dysfunction (CSD). The purpose of our study is to compare 
two methods of physical therapy of CSD: suboccipital relaxation and the McKenzie method. Their effect on 
perceived pain level and life quality was assessed using VAS and NDI scores. Serum levels of biochemical 
stress indicators like testosterone and cortisol were also evaluated. Eighty-six adult patients were divided 
into two groups: Group A and Group B. Group A included 42 patients treated using the McKenzie method. 
Group B consisted of 44 patients who underwent suboccipital relaxation. The therapy in both groups includ-
ed three treatment sessions over a six-week period. Testosterone and cortisol levels were assessed using 
the ELISA technique. Pain evaluation was performed using the Visual Analogue Scale (VAS). The disability 
level was evaluated with the Neck Disability Index (NDI). In both groups, a similar improvement in VAS 
and NDI scores was observed. A distinct cortisol level decrease in patients subjected to the suboccipital 
relaxation was noticed, while the McKenzie method did not affect cortisolaemia significantly. We did not 
notice any difference in testosterone levels between the two groups. Both treatment methods contributed 
towards clinical improvement in our patients, represented by the drop in VAS and NDI scores. We also 
observed a biochemical improvement: decreased cortisol level in the group treated with suboccipital 
relaxation. Due to the important role of testosterone and cortisol in the pathogenesis of chronic pain, our 
study should be the pilot experience on their use as markers in CSD.
Key words: cortisol; testosterone; McKenzie therapy; suboccipital relaxation
Med Res J 2020; 5 (1): 34–40
Corresponding author: 
Paweł Kiczmer 
Department of Medical  
and Molecular Biology,  




Medical Research Journal 2020;
Volume 5, Number 1, 34–40
10.5603/MRJ.a2020.0007
Copyright © 2020 Via Medica
ISSN 2451–2591
Introduction
In recent years, cervical spine dysfunction (CSD) 
has become a significant economic and health problem 
[1, 2]. The development of utility electronics, sedentary 
mode of life and locomotion, coupled with a lack of 
health awareness are the key factors contributing to 
vertebral dysfunctions [3]. Nowadays, CSD is regarded 
as a common disease and includes a group of symp-
toms with pain, limited mobility, and tenderness [4]. 
Furthermore, the early symptoms are often ignored or 
masked by the use of easily available over-the-count-
er (OTC) analgesics [5]. Proper spine functioning is 
affected by its shape [1, 6], vertebral muscle tension, 
vertebral ligaments, joints, discs, nerves, and sensory 
organs. Each of these elements plays a substantial role 
in maintaining somatosensory integrity [7]. Impairment 
of any of above-mentioned components may contribute 
towards certain types of spine dysfunction, i.e. overload-
ing of spinal joints causes instability of trunk segments. 
Common causes of the early stages of CSD include 
cervical spine kyphosis and loss of cervical lordo-
sis. These changes of the cervical segment can not 
only displace the dural sac, but also affect the muscles 
and the ligaments of the posterior, anterior, and central 
column. Subsequent posterior displacement of the nu-
cleus pulposus may result in protrusion of the annulus 
fibrosus towards the spinal canal. This may lead to nerve 
root remodelling and increases the pressure exerted on 
the nerve structures [8].
The compression of the nerve roots impairs proper 
functioning of the brachial and cervical plexuses. This 
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leads to symptoms such as pain, paraesthesia, muscle 
weakness, or weakening of motion range in one or 
more segments. It may also cause a dysfunction of the 
peripheral nerves [9]. 
Re-establishing proper posture, as close as possible 
to the physiological cervical lordosis, is one of the first 
steps of CSD treatment [6]. The restoration of proprio-
ception in the suboccipital area is another key factor in 
the process. Adequate functioning of proprioception re-
ceptors relies not only on proper circulation and muscle 
tone, but also on patient education regarding correct 
posture. These therapeutic goals can be achieved using 
two methods: mechanical diagnosis and therapy (MDT, 
also called the McKenzie method) and suboccipital 
relaxation [10].
The idea behind the McKenzie method (MDT) is to 
restore the two basic motion patterns in the cervical 
spine — retraction and hyperextension. Retraction 
is the backward head movement which creates lor-
dosis. Hyperextension affects the displaced nucleus 
pulposus [11] and relaxes the posterior ligament struc-
tures, thus relieving the pressure exerted on the nerves 
[12]. In some patients, therapy also includes cervical 
spine traction.
Suboccipital relaxation is an osteopathic method 
targeting the structures of the craniospinal region as 
well as the surrounding soft tissue [13]. It results in 
relaxation of these structures, lowers the muscle tone, 
and reduces blood stasis in the now relaxed suboccip-
ital and perivertebral muscles [14].
The purpose of our study was to asses two methods 
of physical therapy for CSD: suboccipital relaxation and 
the McKenzie method. Their effect on the perceived 
pain level and life quality was evaluated using the VAS 
and NDI scales. Additionally, we analysed salivary 
concentrations of chronic pain biomarkers to evaluate 
the results of the examined methods.
Material and methods 
Study was designed according to the CONSORT 
statement [15]. Eighty-six adult patients who met the 
inclusion criteria were divided into two groups: Group 
A and Group B. Group A included 42 patients (34 wom-
en, eight men) treated using the McKenzie method. 
Group B consisted of 44 patients (33 women, 11 men) 
subjected to suboccipital relaxation. The average age 
was 50.1 years (SD = 10.4, range 26 –64) in the first 
group and 48.1 years (SD = 10.8, range 26 –64) in the 
second group. There were no statistically significant 
differences in age or gender ratio between the two 
groups (p > 0.05).
No changes of trial design were made during the 
experiment. We assumed that the sample size should 
include 40 patients, which is the medium number of 
cervical spondylosis cases in our centre per month. 
In each case, CSD was confirmed using magnetic 
resonance imaging (MRI). Inclusion criteria comprised 
diagnosis of cervical spine pain lasting more than four 
weeks, loss or restriction of movement in the cervical 
spine, spondylosis and spondyloarthrosis with per-
sistent or intermittent pain or CSD-related headaches, 
patient’s age > 18 years, and signed consent for par-
ticipation. We excluded patients with cervical spine or 
head trauma, muscle weakness caused by a critical 
stenosis of the spinal or root canal, coexistence of carpal 
tunnel syndrome or ulnar nerve compression, constant 
pain-relieving pharmacotherapy, drug abuse, neoplastic 
diseases, myasthenia gravis, steroid therapy, antibiotic 
or antiviral therapy, Cushing’s syndrome, Arnold-Chiari 
syndrome, syringomyelia, and other congenital defects 
of the head and the cervical area. Lack of informed 
consent was also an excluding factor. The study was 
approved by the Committee on Research Ethics of the 
Silesian Chamber of Physicians (Komisja Bioetyczna 
Śląskiej Izby Lekarskiej No. 46/2015).
Every patient underwent three treatment sessions, 
one in every three weeks. The pain assessment was 
performed two times using the VAS scale – at the be-
ginning of the experiment and after the last session. The 
disability level was evaluated with the NDI scale, before 
the first treatment session and after the last one. To 
assess the hormone levels, saliva was collected using 
“salivette” type test tubes. The patients had to abstain 
from certain activities for 20 minutes before the sample 
collection. The restrictions included eating, cigarette 
smoking, tooth brushing, gum chewing, and drinking. 
After collection the samples were centrifuged and frozen 
at –85°C for storage. The laboratory examinations were 
performed in the Chair and Department of Medical and 
Molecular Biology of the Faculty of Medical Sciences 
in Zabrze, Medical University of Silesia in Katowice.
VAS (visual analogue scale)
The VAS is a reliable tool for the assessment of pain 
intensity. The scale is represented by a 10 cm coloured 
ruler, with its ends defining the extreme limits. The left 
margin represents a lack of pain, while the right one 
represents the strongest pain imaginable. Patients 
indicate the pain level by using their finger [16, 17].
NDI (neck disability index)
The NDI is a questionnaire to be completed by the 
patient. It includes 10 questions assessing the impact of 
neck pain on daily life activities. The index can be used 
as a self-report measure of neck pain [18].
36
Medical research journal 2020, vol. 5, no. 1
www.journals.viamedica.pl/medical_research_journal
Assessment of testosterone and cortisol levels 
In order to evaluate the testosterone and cortisol 
levels, commercial ELISA tests (DiaMetria Italy) were 
used. Absorbance assessment was performed using 
the µQuant reader (BioTek USA), and the obtained data 
were analysed with KCJunior software (BioTek USA). 
Method sensitivity for cortisol was 0.12 ng/mL, and for 
testosterone it was 3.28 pg/mL. Method inaccuracy for 
cortisol was 6.2%, and for testosterone it was 7.9%. 
Statistical analysis
Statistical analysis of the data was performed 
using Statistica 13 PL software. The patient age was 
expressed as the average +/ – standard deviation (SD). 
To compare the age in both groups, Student’s t-test was 
used. The Shapiro-Wilk test was used to determine dis-
tributions of variables. Non-normal variables were pre-
sented as median with interquartile range. To compare 
non-parametric variables the Mann Whitney U-test was 
performed for comparison of groups and the Wilcoxon 
test to assess differences between initial and final values 
of analysed variables. Two-way ANOVA for repeatable 
measurements was performed to assess the effect of 
gender on testosterone concentration before and after 
treatment. P values < 0.05 were considered significant.
Results 
We observed a significant decrease in perceived 
pain expressed as VAS score in both groups (Tab. 1, 
Fig. 1). There was no significant difference in VAS values 
Table 1. VAS, NDI, testosterone, and cortisol values before and after treatment
McKenzie Method
  Before treatment After treatment p
VAS 4 (3–5) 1 (0–2) < 0.001
NDI 15 (10–19) 9 (6–13) < 0.001
Testosterone [pg/mL] 53.4 (49.7–59.7) 55.8 (49.8–59.8) < 0.001
Cortisol [ng/mL] 22.5 (19.5–26.8) 23.5 (22.3–26.7) 0.95
Suboccipital relaxation
  Before treatment After treatment  p
VAS 4 (3–5) 1 (0–3) < 0.001
NDI 15 (10–19) 9 (6–13) < 0.001
Testosterone [pg/mL] 55.3 (49.85–59.8) 53.8 (51.3–55.4) 0.07













Before treatment After treatment
Figure 1. VAS scores among examined groups before and 
after therapy. Data presented as median with interquartile 
range; VAS — visual analogue scale
between groups at the beginning of the experiment, nor 
after treatment (Tab. 2). A significant drop in salivary 
testosterone levels was observed among patients who 
underwent McKenzie treatment (Tab. 1). 
Significant decreases of NDI values were observed 
in both groups (Tab. 1, Fig. 2). There was no difference 
in NDI values between groups at the beginning of ex-
periment and at the outcome (Tab. 2).
We found no significant decrease of testosterone 
level in the group treated with suboccipital relaxation. 
There was no difference in testosterone concentration 
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between the examined groups at first measurement; 
however, its concentration after therapy was signifi-
cantly lower in the group that underwent suboccipital 
relaxation (Tab. 2, Fig. 3).
We did not observe significant changes in cortisol 
concentration among patients who underwent McKen-
zie Therapy (Tab. 1, Fig. 4). A significant drop in hor-
mone concentration was observed in the suboccipital 
relaxation group. There were no significant differences 
in cortisol concentrations between the examined groups 
at the beginning and after therapy.
Table 2. Comparison of values of examined parameters among groups
Before treatment
  McKenzie method Suboccipital relaxation p
VAS 4 (3–5) 4 (3–5) 0.86
NDI 15 (10–19) 15 (10–19) 0.65
Testosterone 53.4 (49.7–59.7) 55.3 (49.85–59.8) 0.50
Cortisol [ng/mL] 22.5 (19.5–26.8) 22.6 (19.5–26.6) 0.97
After treatment  
  McKenzie method Suboccipital relaxation p
VAS 1 (0–2) 1 (0–3) 0.70
NDI 9 (6–13) 9 (6–13) 0.59
Testosterone [pg/mL] 55.8 (49.8–59.8) 53.8 (51.3–55.4) < 0.001
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Figure 2. NDI scores among examined groups before and 
after therapy. Data presented as median with interquartile 
range; NDI — neck disability index
Discussion
Both methods compared in our paper are effective 
and life-quality improving treatment options for patients 
with CSD. The McKenzie method is an efficient means of 
achieving relaxation of cervical muscles and diminishing 
tension headaches [19]. Kjellman et al. [20] reported 
a significant improvement of quality of life in patients 
treated using this method. However, Clare et al. [10] 
in their systematic review did not prove the unambig-
uous efficiency of the McKenzie method due to a lack 
Figure 3. Salivary testosterone levels among examined 
groups before and after therapy. Data presented as median 
with interquartile range
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of scientific evidence. A decrease in the VAS scores 
in patients who underwent the McKenzie therapy was 
reported by Moffet et al. [21]. The authors compared 
it to physiotherapy and did not report a significant 
advantage of either method. Suboccipital relaxation 
therapy has also been found to be effective in CSD, and 
its efficiency has been observed in the management of 
tension headaches [22]. The latter was also reported 
by Jung Yang et al. [23]. 
In our study, a significant decrease in perceived pain 
level over time was observed in both groups, without 
any significant differences in pain relapse. However, 
a proper verification of these results would require 
a larger sample size. Both methods were shown to not 
only alleviate the pain related to the CSD, but also to 
increase the quality of life evaluated using the NDI score. 
We did not observe any differences in efficiency be-
tween them. Currently, scientific papers on the subject 
are scarce, out of which only a few attempted scientific 
validation by evaluating the levels of biochemical pain 
indicators. In an attempt to objectify our results, we 
did not limit them to a subjective assessment of pain 
perceived by the patient, but we also measured the 
testosterone and cortisol levels.
Chronic pain may not only alter cortisol excretion, 
exacerbating the symptoms of CSD [24], but may also 
affect the circadian rhythm of hormones. Analgesia has 
been observed to normalise serum cortisol levels [25]. 
In our study, we attempted to verify whether both meth-
ods are equally efficient in pain alleviation. We observed 
a significant cortisol drop only among patients who un-
derwent suboccipital relaxation therapy. No differences 
in cortisol level were found in group that underwent the 
McKenzie method treatment. However, longer observa-
tion of a study group comprising a larger sample size 
would be needed to confirm this effect; therefore, we 
cannot rule out the possibility of the decrease being 
accidental. Salivary cortisol level increase after cervi-
cal manipulations was also reported in a randomised, 
controlled trial performed by Valera-Calero et al. [26]. 
Similar results were reported by Plaza-Manzano et al. 
However, they did not observe differences in pre- and 
post-treatment cortisol level [27]. Nonetheless, it should 
be noted that the authors used peripheral blood sam-
ples to measure the hormone levels while collecting 
them, which may be associated with additional stress in 
the patient. Further research is needed in order to verify 
the data that were obtained. Analysis of salivary cortisol 
levels in patients was performed by Moyer et al. in their 
meta-analysis. The authors concluded that massage 
has no significant effect on the hormone concentration, 
based on 18 studies [28]. However, their work analysed 
studies of patients suffering from various medical con-
ditions. In order to precisely assess the CSD-related 
cortisol fluctuations, further studies are needed [28]. 
The authors emphasise that a lack of influence on the 
cortisol levels does not prove the ineffectiveness of 
manual therapy. For instance, the high-velocity low-am-
plitude (HVLA) chiropractic method was shown to have 
no influence on the hormone concentration [29]. Sobas 
et al. [30] consider cortisol level to be an unreliable pain 
biomarker due to its changeability. Many other factors, 
such as the time of the day or stress, may cause alter-
ations in cortisol levels.
Testosterone and cortisol are two hormones that 
play an important role in the pathogenesis of chronic 
pain. The latter is synthesised in the adrenal cortex, 
and its release follows a characteristic circadian rhythm 
[31–33]. It is responsible for proper glucose metabo-
lism, regulation of the protein catabolism, and mainte-
nance of functions of the liver and the gastrointestinal 
tract. Moreover, cortisol exhibits immunosuppressive 
properties and can be used as an anti-inflammatory 
drug. It is also an important element of natural response 
to stress of the human body. A short-term increase of 
cortisol levels is considered beneficial [34]. However, 
prolonged stress may disrupt these physiological 
mechanisms, and chronic pain has been identified as an 
underlying cause of an abnormal stress response [35]. 
The early anti-inflammatory effect of cortisol is eventually 
suppressed due to steroid receptor downregulation, 
subsequently disrupting synthesis of the hormone. 
This may result in destabilisation of its circadian rhythm 
[36], leading to either hyper- or hypocortisolism. The 
dysfunctions in cortisol excretion ultimately lead to the 























Figure 4. Salivary cortisol levels among examined groups 
before and after therapy. Data presented as median with 
interquartile range
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Testosterone is synthesised in the gonads and the 
adrenal cortex. Its level correlates negatively with expo-
sure to stress [37]. A suppressing effect of testosterone 
on the hypothalamic-pituitary-adrenal (HPA) axis has 
been observed [24]. Furthermore, it has been proven 
to affect pain perception in patients with fibromyalgia 
and other diseases [38]. There is a correlation between 
gonadectomy and increased susceptibility to pain in 
rats [39, 40]. 
The analgesic effect of testosterone was first de-
scribed in the 1990s [41]. The hormone exerts a sup-
pressing effect on inflammatory mediators, as observed 
during antiandrogen therapy [42]. Testosterone also 
[38] exhibits a central effect — its concentration is 
positively correlated with middle frontal cortex activity, 
reducing pain in patients of both sexes [43]. The results 
of the aforementioned studies indicate that testosterone 
plays an important role in pain diminishment. In our 
study we observed significant drop of testosterone 
concentration among patients who underwent the 
McKenzie method and no significant changes among 
patients treated with suboccipital relaxation. We could 
not find any studies evaluating testosterone levels in 
cervical spine disorders. It is considered that exposure 
to stress factors, such as chronic pain is associated 
with a lower testosterone concentration. Some authors 
suggest that pain perception is negatively correlated 
with testosterone levels [44]. 
Conclusions
In our study, both methods were found to positively 
affect the condition of the patients as represented by 
the improvement in VAS and NDI scores. No signifi-
cant advantage of either method was observed. While 
there were no differences in testosterone concentration 
between the methods, suboccipital relaxation was 
associated with a significant decrease in cortisol level. 
However, we were unable to assess which method is 
more efficient. To the best of our knowledge, to date 
there have been no other studies comparing the McKen-
zie method with suboccipital relaxation, nor correlating 
them with testosterone and cortisol levels. We were 
unable to indicate superiority of either method due 
to the limitations of our work: small sample sizes and 
a relatively short period of observation. Nonetheless, 
our results indicate a significant improvement in the 
life quality of the patients, represented by a drop in the 
VAS and NDI scores. These results may be considered 
as a background for further research evaluating the use 
of the suboccipital relaxation and the McKenzie method 
in cervical spine disorders.
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